Top Markets
Coin of the day
Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.

Odonate Therapeutics, Inc.

ODTC
Rangering i aksjer #18159
Odonate Therapeutics, Inc., a pharmaceutical company established in 2013 and... Odonate Therapeutics, Inc., a pharmaceutical company established in 2013 and headquartered in New York, New York, is dedicated to creating treatments for cancer. Its primary therapeutic in development is tesetaxel, an orally administered chemotherapy drug. This agent is currently undergoing a Phase III clinical study for its application in patients suffering from metastatic breast cancer.
Aksjekurs
$150,000
Sist synkronisert: 2025-02-11
Markedsverdi
$210.38M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Odonate Therapeutics, Inc. (ODTC)

Kategori

Utbytteavkastning for Odonate Therapeutics, Inc. (ODTC)
Odonate Therapeutics, Inc. (aksjesymbol: ODTC) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Odonate Therapeutics, Inc. (ODTC) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
Selskap Utbytteavkastning Land
0.00%
US
0.00%
NL
0.00%
US
2.48%
AU
0.00%
CH